Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0000502 | proteasome complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0140535 | intracellular protein-containing complex | 2 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1905368 | peptidase complex | 3 | 2 |
GO:1905369 | endopeptidase complex | 4 | 2 |
Related structures:
AlphaFold database: A4H9M0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 266 | 270 | PF00656 | 0.416 |
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.481 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.414 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.318 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.579 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 289 | 293 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.277 |
DEG_APCC_DBOX_1 | 203 | 211 | PF00400 | 0.337 |
DEG_SCF_FBW7_1 | 97 | 103 | PF00400 | 0.256 |
DOC_CKS1_1 | 97 | 102 | PF01111 | 0.500 |
DOC_CYCLIN_RxL_1 | 206 | 216 | PF00134 | 0.449 |
DOC_MAPK_MEF2A_6 | 8 | 16 | PF00069 | 0.497 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.703 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.415 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 193 | 198 | PF00397 | 0.227 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.463 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.334 |
LIG_14-3-3_CanoR_1 | 120 | 129 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 162 | 172 | PF00244 | 0.453 |
LIG_14-3-3_CanoR_1 | 225 | 235 | PF00244 | 0.353 |
LIG_BIR_III_2 | 176 | 180 | PF00653 | 0.499 |
LIG_BIR_III_4 | 191 | 195 | PF00653 | 0.501 |
LIG_BRCT_BRCA1_1 | 273 | 277 | PF00533 | 0.473 |
LIG_BRCT_BRCA1_1 | 30 | 34 | PF00533 | 0.415 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.358 |
LIG_FHA_2 | 261 | 267 | PF00498 | 0.486 |
LIG_FHA_2 | 40 | 46 | PF00498 | 0.480 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.540 |
LIG_LIR_Gen_1 | 263 | 269 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 123 | 128 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 263 | 267 | PF02991 | 0.274 |
LIG_PCNA_APIM_2 | 287 | 293 | PF02747 | 0.419 |
LIG_PCNA_yPIPBox_3 | 233 | 246 | PF02747 | 0.388 |
LIG_PCNA_yPIPBox_3 | 284 | 298 | PF02747 | 0.389 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 290 | 293 | PF00017 | 0.391 |
LIG_SH3_3 | 104 | 110 | PF00018 | 0.356 |
LIG_SH3_3 | 166 | 172 | PF00018 | 0.519 |
LIG_SUMO_SIM_anti_2 | 9 | 17 | PF11976 | 0.333 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.525 |
MOD_CK2_1 | 245 | 251 | PF00069 | 0.465 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.612 |
MOD_CK2_1 | 39 | 45 | PF00069 | 0.627 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.534 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.750 |
MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.484 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.221 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.151 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.459 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.302 |
MOD_GSK3_1 | 39 | 46 | PF00069 | 0.665 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.458 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.339 |
MOD_N-GLC_1 | 143 | 148 | PF02516 | 0.747 |
MOD_N-GLC_1 | 253 | 258 | PF02516 | 0.469 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.441 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.287 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.425 |
MOD_PKA_1 | 252 | 258 | PF00069 | 0.472 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.464 |
MOD_Plk_1 | 118 | 124 | PF00069 | 0.525 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.596 |
MOD_ProDKin_1 | 193 | 199 | PF00069 | 0.161 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.461 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.330 |
MOD_SUMO_rev_2 | 156 | 165 | PF00179 | 0.705 |
MOD_SUMO_rev_2 | 248 | 255 | PF00179 | 0.296 |
MOD_SUMO_rev_2 | 299 | 308 | PF00179 | 0.445 |
TRG_DiLeu_BaEn_2 | 240 | 246 | PF01217 | 0.449 |
TRG_DiLeu_BaLyEn_6 | 194 | 199 | PF01217 | 0.337 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.376 |
TRG_NES_CRM1_1 | 13 | 26 | PF08389 | 0.292 |
TRG_Pf-PMV_PEXEL_1 | 115 | 119 | PF00026 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.337 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8U8 | Leptomonas seymouri | 57% | 100% |
A0A0S4KHT8 | Bodo saltans | 32% | 100% |
A0A1X0P783 | Trypanosomatidae | 42% | 97% |
A0A3S7WV17 | Leishmania donovani | 82% | 100% |
A0A3S7X3U4 | Leishmania donovani | 24% | 76% |
A0A422P0K3 | Trypanosoma rangeli | 45% | 100% |
A4HXY4 | Leishmania infantum | 82% | 100% |
A4I610 | Leishmania infantum | 24% | 76% |
D0A5C3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9ARP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
E9B1A1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 76% |
Q4Q6W3 | Leishmania major | 24% | 76% |
Q4QDT2 | Leishmania major | 82% | 100% |
Q8Q0U0 | Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88) | 25% | 86% |
V5BJ76 | Trypanosoma cruzi | 47% | 100% |